Skip to main content

Systemic Lupus Erythematosus News

Related terms: Disseminated Lupus Erythematosus, Lupus, SLE

FDA Approves Belimumab Autoinjector for Pediatric Systemic Lupus Erythematosus

WEDNESDAY, May 22, 2024 – The U.S. Food and Drug Administration has approved a 200-mg subcutaneous route of administration of Benlysta (belimumab) for patients 5 years of age and older with active...

Neuropsychiatric Symptoms Can Present at Any Stage of Lupus

TUESDAY, May 21, 2024 – For patients with systemic lupus erythematosus (SLE), neuropsychiatric (NP) symptoms can first present at any stage in the disease course, according to a study published...

Rheumatic Diseases Have an Impact on Reproductive Health

WEDNESDAY, April 3, 2024 – Rheumatic diseases have a broad impact on reproductive success and pregnancy outcomes, according to a study published online March 20 in Rheumatology. Anne M. Kerola, ...

Lupus, Type 1 Diabetes Linked to Pregnancy Complications

WEDNESDAY, March 20, 2024 – People with autoimmune disorders such as lupus, type 1 diabetes and rheumatoid arthritis tend to have fewer children, and women with this class of illnesses often have...

CAR T-Cell Therapy Feasible, Safe for Autoimmune Diseases

WEDNESDAY, Feb. 21, 2024 – CD19 chimeric antigen receptor (CAR) T-cell therapy seems feasible, safe, and efficacious for patients with different autoimmune diseases, according to a study published...

Obinutuzumab Preserves Kidney Function in Lupus Nephritis

THURSDAY, Nov. 16, 2023 – For patients with lupus nephritis (LN), obinutuzumab treatment results in better preservation of kidney function and prevention of LN flares, according to a study published...

COVID Might Raise Odds for Immune Disorders Like Crohn's, Alopecia

TUESDAY, Oct. 10, 2023 – In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report. Conditions such as alopecia (hair loss), psoriasis,...

Ginger May Ease Inflammation of Autoimmune Diseases

MONDAY, Sept. 25, 2023 – Ginger supplements may help those with certain autoimmune diseases, such as lupus and rheumatoid arthritis, control inflammation. New research has added evidence to support...

Racial Discrimination Linked to Increased CRP in Black Women With Lupus

MONDAY, Aug. 14, 2023 – For Black women with systemic lupus erythematosus (SLE), incident racial discrimination is associated with elevated C-reactive protein (CRP), according to a study published...

FDA Approves Saphnelo (anifrolumab) for Moderate to Severe Systemic Lupus Erythematosus

2 August 2021 – AstraZeneca’s Saphnelo (anifrolumab-fnia) has been approved in the US for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving ...

GSK Receives US Approval of Benlysta for Intravenous Use in Children with Lupus Aged Five Years and Above

London UK, Philadelphia USA April 26, 2019 – GSK today announced that the US Food and Drug Administration (FDA) has approved, under priority review, the use of the intravenous (IV) formulation of...

GSK Receives FDA Approval for a New Self-Injectable Formulation of Benlysta (belimumab) for Systemic Lupus Erythematosus

London, UK 21 July 2017 – GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult patients...

FDA Approves Benlysta to Treat Lupus

March 9, 2011 – The U.S. Food and Drug Administration today approved Benlysta (belimumab) to treat patients with active, autoantibody-positive lupus (systemic lupus erythematosus) who are receiving...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

prednisone, aspirin, triamcinolone, hydroxychloroquine, Plaquenil, cortisone, dexamethasone, Benlysta